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Human RAD50 Deficiency in a
Nijmegen Breakage Syndrome-like Disorder
Regina Waltes,1,2,9 Reinhard Kalb,3,9 Magtouf Gatei,4 Amanda W. Kijas,4 Markus Stumm,5
Alexandra Sobeck,3 Britta Wieland,1,2 Raymonda Varon,6 Yaniv Lerenthal,7
Martin F. Lavin,4,8 Detlev Schindler,3,* and Thilo Do¨rk1,*
The MRE11/RAD50/NBN (MRN) complex plays a key role in recognizing and signaling DNA double-strand breaks (DSBs). Hypomorphic
mutations in NBN (previously known as NBS1) andMRE11A give rise to the autosomal-recessive diseases Nijmegen breakage syndrome
(NBS) and ataxia-telangiectasia-like disorder (ATLD), respectively. To date, no disease due to RAD50 deﬁciency has been described. Here,
we report on a patient previously diagnosed as probably having NBS, with microcephaly, mental retardation, ‘bird-like’ face, and short
stature. At variance with this diagnosis, she never had severe infections, had normal immunoglobulin levels, and did not develop
lymphoid malignancy up to age 23 years. We found that she is compound heterozygous for mutations in the RAD50 gene that give
rise to low levels of unstable RAD50 protein. Cells from the patient were characterized by chromosomal instability; radiosensitivity;
failure to form DNA damage-induced MRN foci; and impaired radiation-induced activation of and downstream signaling through the
ATM protein, which is defective in the human genetic disorder ataxia-telangiectasia. These cells were also impaired in G1/S cell-
cycle-checkpoint activation and displayed radioresistant DNA synthesis and G2-phase accumulation. The defective cellular phenotype
was rescued by wild-type RAD50. In conclusion, we have identiﬁed and characterized a patient with a RAD50 deﬁciency that results in
a clinical phenotype that can be classiﬁed as an NBS-like disorder (NBSLD).Introduction
Deﬁciencies in DNA double-strand break (DSB) signaling
and repair are hallmarks of distinctive neurodegenerative
syndromes.1,2 Germ-line mutations in the ATM and
MRE11A genes underlie the autosomal-recessive cerebellar
ataxia syndromes ataxia-telangiectasia (A-T [MIM208900])3
and ataxia-telangiectasia-like disorder (ATLD [MIM
604391]),4 whereas germ-line mutations in theNBN (previ-
ously termed NBS1) gene are responsible for the Nijmegen
breakage syndrome (NBS [MIM 251260]), an autosomal-
recessive disorder characterized by microcephaly, growth
retardation, immunodeﬁciency, radiosensitivity, and
cancer predisposition.5,6 The MRE11/RAD50/NBN (MRN)
complex is a highly conserved protein complex implicated
in both homologous recombination repair (HRR) and
nonhomologous end joining (NHEJ) of DNA DSBs,7,8 in
telomere maintenance, and in DNA replication.9,10 This
protein complex acts as a sensor of DSBs and recruits the
ataxia telangiectasia mutated (ATM) protein to sites of the
breaks, where it is activated.11–13
TheMRN complex is rapidly relocalized to nuclear foci in
response to irradiation of cells.14 It was shown that ATM,
which phosphorylates NBN for activation of the S-phase
checkpoint, was not required for association of the MRN
complex with sites of DNA damage.15 The complex also
binds tightly to chromatin during normal S phase.16 TheThe Aminitial event in recognizing and responding to DSBs is the
binding of a RAD50/MRE11 heterotetramer (R/M complex)
to DNA, tethering broken ends of DSBs.17 This binding is
achieved through the two DNA-binding motifs of MRE11
and is arranged as a globular domain with RAD50 Walker
A and B motifs (ATPase domains). The bridging of DNA
molecules is achieved through CXXC sequences in the
middle part of RAD50.18 These sequences occur at the
ends of a 960-aa-long heptad repeat coiled-coil region and
appear to dimerize by the coordination of a Zn2þ ion.19
The dynamic architecture of the MRN complex is altered
for parallel orientation of the coiled coils of RAD50,
favoring intercomplex association.20 The exonuclease and
endonuclease activities ofMRE11 are stimulated upon asso-
ciation with RAD50.21,22 NBN also stimulates its endonu-
clease activity.23 The complete complex can partly unwind
or dissociate a short DNA duplex with a 30 overhang, and
this activity is stimulated by ATP.23
MRNis required for full activationofATMat theDSB.24As
part of its engagement, ATM is recruited to DNA ﬂanking
the DSB, where it is activated by autophosphorylation.25,26
Conversion of an inactive dimer to an active monomer is
part of this process. The likely sequence of events has
recently been elucidated at deﬁned endogenous DSBs.27,28
The initial activation of ATMappears to occur by relaxation
of chromatin, followed by local disruption of the nucleo-
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at the break, and subsequent admittance of DNA-repair
proteins. Once activated, ATM can then phosphorylate
a multitude of downstream substrates involved in DNA
repair, cell-cycle control, and regulation of transcrip-
tion.29,30 NBN is one of these substrates and plays a role as
adaptor for the phosphorylation of downstream substrates
involved in regulating S-phase checkpoints.31 No disorder
has been associated with biallelic mutations in RAD50,
thus far. Here, we report on a patient with a variant form
of NBS, who revealed RAD50 protein deﬁciency due to
two germline mutations in the RAD50 gene.
Material and Methods
Cell Cultures and Treatments
Blood samples and skin biopsies were obtained with informed
consent of the patients and parents. The procedures followed the
ethical standards of institutional committees. Whole blood was
stimulated by 2.5% phytohemagglutinin. Lymphoblast cell lines
(LCLs) were established from Ficoll-isolated blood lymphocytes
via transformation by Epstein-Barr virus. Primary ﬁbroblast-like
cells were grown from skin explants. The RAD50-deﬁcient ﬁbro-
blasts, but not those of the heterozygous parents, displayed prema-
turely senescent morphology and behavior, with diminished
growth rates, even at early passages. Suspension cell cultures were
maintained in RPMI 1640, adherent cultures in Earle’s MEM, both
with GlutaMAX (Invitrogen, Karlsruhe, Germany), supplemented
with 15% heat-inactivated FBS (Sigma, Taufkirchen, Germany), in
a humidiﬁed atmosphere with 5% CO2 at 37
C. Ionizing radiation
(IR) employed either a 60Co- or an X-ray source (dose rates approx-
imately 1.5 Gy/min), both controlled by dosimetry.
For assessment of univariate cell-cycle distributions, lympho-
blasts were harvested 48 hr after IR, lymphocytes and ﬁbroblasts
72 hr after IR. The cells were permeabilized, and nuclei were
stained with 4 mg/ml DAPI for 30min in the dark. Flow histograms
were recorded on an analytical dual-laser-equipped ﬂow cytometer
(LSR1, BD Biosciences, Heidelberg, Germany). Curves were ﬁtted
and quantiﬁed in the MPLUS AV software package (Phoenix
Flow Systems, San Diego, CA).
Genomic Workup
Total RNA and genomic DNA were isolated from peripheral white
blood cells, lymphoblasts, and ﬁbroblasts. RNA was reverse-tran-
scribed with the use of random hexamers (Amersham Bioscience,
Munich, Germany) for priming of ﬁrst-strand cDNA synthesis.
The entire RAD50 coding region was PCR ampliﬁed from the
patient´s samples and sequenced in ten overlapping fragments
with primers derived from the published cDNA sequence. For
the ampliﬁcation of genomic DNA, we constructed primers based
on exon-ﬂanking intron sequences of the RAD50 gene. Primer
sequences and genomic PCR conditions are provided in Table S1,
available online.
Sequencing of the puriﬁed PCR products required dye-termi-
nator chemistry on ABI 310 instruments (Applied Biosystems,
Darmstadt, Germany) with reagents supplied by themanufacturer.
Nucleotide sequence changes are numbered according to the
sequence of the major RAD50 mRNA (transcript variant 1, Gen-
Bank NM_005732.2), starting with the ﬁrst nucleotide of the initi-
ation codon; likewise, changes of the protein sequence were
described according to the recommendations of the Human606 The American Journal of Human Genetics 84, 605–616, May 15Genome Variation Society. For further genotype analysis, we
used restriction-enzyme digestion of exon 21 and exon 25 PCR
products, followed by electrophoresis of the fragments on 2%
agarose gels. The c.3277C/T substitution destroyed a TaqI site
of the wild-type (WT) exon 21 PCR product (185 and 146 bp frag-
ments) and left the PCR product of 331 bp from the mutant allele
uncleaved. The c.3939A/T substitution created a new recogni-
tion site for PsiI that resulted in fragments of 285 and 52 bp
from the mutant allele, compared to a single WT exon 25 PCR
product of 337 bp. Restriction enzymes were purchased from
New England BioLabs (Ipswich, MA).
Protein Analysis
Subcultures of lymphoblast or ﬁbroblast lineswere left untreated or
exposed to 6 Gy of ionizing radiation and harvested 30 min after
irradiation. Extractswereprepared by resuspending the cells in lysis
buffer (50 mM Tris-HCl pH 7.4, 150 mMNaCl, 2 mM EGTA, 2 mM
EDTA, 25 mM NaF, 25 mM b-glycerophosphate, 0.1 mM ortho-
vanadate, 0.1mMphenylmethylsulfonyl ﬂuoride, 5 mg/ml leupep-
tin, 1 mg/ml aprotinin, 0.2%TritonX-100, and 0.3%nonidet P-40),
followed by incubation on ice for 30 min. Supernatants were
collectedafter centrifugationat13,0003 g for 10min. For thedeter-
mination of relative RAD50, NBN, and MRE11 protein levels and
the extent of radiation-induced NBN phosphorylation, whole-cell
extracts were separated by SDS-PAGE at 20 mg total protein per
lane. The gels were blotted ontoHybond-C (AmershamPharmacia,
Munich, Germany) nitrocellulose membranes at 35 V for 3 to 4 hr
with the use of carbonate buffer (10 mMNaHCO3, 3 mMNa2CO3,
pH9.9)with20%methanol.Alternatively, 7%Tris-AcetateGels (In-
vitrogen, Karlsruhe, Germany) and buffers supplied by the manu-
facturer were used. After blocking with 5% skim milk and 0.05%
Tween 20 (Sigma, Taufkirchen, Germany) in PBS, membranes
were probed with appropriate antibodies. These included mouse
monoclonal anti-RAD50 (RAD50-13B3, diluted 1:5000, GeneTex,
San Antonio, TX), rabbit polyclonal NBN antiserum (anti-p95,
diluted 1:5000, Novus Biologicals, Littleton, CO) or mouse mono-
clonal anti-MRE11 (MRE11-12D7, diluted 1:400, GeneTex, San
Antonio, TX); mouse monoclonal anti-phospho p53 (serine-15)
(diluted 1:1000, New England Biolabs, Ipswich, MA); rabbit poly-
clonal anti-CHEK1 pSer317 (1:1000, Cell Signaling Technology,
Danvers, MA); rabbit polyclonal anti-ATM Ser1981 (1:2000, Rock-
land, Gibertsville, PA);mousemonoclonal anti-ATM (1:2000, Gen-
eTex, San Antonio, TX); mouse monoclonal anti-SMC1 pSer957
(1:2000 Upstate, Charlottesville, VA), and rabbit polyclonal anti-
SMC1 (1:2000, Novus, Littleton, CO). For comparison with a
protein of uniform abundance, blots were reprobed with mono-
clonal anti-b-actin (diluted 1:5000, Sigma, Taufkirchen, Germany).
We used horseradish peroxidase-conjugated rabbit anti-mouse and
goat anti-rabbit IgG secondary antibodies (dilution 1:5000, Sigma,
Taufkirchen, Germany) and enhanced chemiluminescence (ECL,
Pierce/Thermo Fisher Scientiﬁc, Rockford, IL, or Amersham/GE
Healthcare, Munich, Germany) for visualization and autoradiog-
raphy. Immunoblot signals were quantitated densitometrically.
For immunoprecipitation(IP), 220mg (controls)or440mg (HA239)
proteinweremixed after preclearancewithprimary antibody (rabbit
anti-NBN [Novus, Littleton, CO] or rabbit anti-MRE11 [Novus, Lit-
tleton, CO]) for 1 hr and were immunoprecipitated overnight
(4C) by the addition of protein G-Sepharose (Amersham/GE
Healthcare, Munich, Germany). Immunoprecipitates were washed
extensively and separated by denaturating gel electrophoresis. For
immunodetection, various mouse anti-NBN, -MRE11, or -RAD50
were used (all provided by GeneTex, San Antonio, TX)., 2009
Immunoﬂuorescence
Normal control and RAD50-deﬁcient ﬁbroblasts were seeded onto
coverslips in 12-well plates, grown for 24 hr, and exposed to 12 Gy
of ionizing radiation. The cells were incubated for an additional
14 hr with fresh growthmedia, followed by ﬁxation and permeabi-
lisation in 4% paraformaldehyde and 0.1% Triton X-100 for
15 min. After washing with PBS, coverslips were blocked in PBS
with 5% goat serum (Jackson ImmunoResearch, West Grove, PA)
at roomtemperature (RT) for 1hr. Thecellmonolayerswere covered
with rabbit polyclonal NBN antiserum (Novus, Littleton, CO) at
1:100 dilution, rabbit polyclonal MRE11 antiserum (Novus, Little-
ton, CO) at 1:200 dilution, or mouse monoclonal anti-RAD50
(GeneTex, San Antonio, TX) at 1:200 dilution and were incubated
at RT for 1 hr. After washing with PBS, the slides were incubated
with Alexa Fluor 594 goat anti-rabbit IgG or Alexa Fluor 594 goat
anti-mouse conjugate (Molecular Probes), respectively, at 1:200
dilution, for 1 hr at RT. In the case of double-staining, Alexa Fluor
488 goat anti-rabbit IgG was used. Nuclei were counterstained
with DAPI at 1 ng/ml for 2 min. After three ﬁnal washing steps,
the coverslips were mounted in Vectashield mounting medium
(Vector Laboratories, Burlingame, CA). They were examined by
ﬂuorescence microscopy on an Axiophot microscope (Zeiss, Ober-
kochen, Germany). Images of the same nuclei were captured with
the use of Texas red, FITC, andDAPI ﬁlters and an Applied Imaging
System with EasyFish version 1.2 software.
Complementation Assays
Human RAD50 cDNA in pFLAG-1 vector (Kodak Scientiﬁc Imaging
Systems,NewHaven,CT)was a generousgift ofK.K.Kim,Kwangju,
South Korea. The coding region was ampliﬁed by PCR and subcl-
oned into the vector pREP4 (Invitrogen, Karlsruhe, Germany)
with the use of BamHI andNotI restriction sites. Transient transfec-
tion of lymphoblastoid cells was achieved by lipofection with
FuGene (Roche, Mannheim, Germany) in accordance with the
manufacturer’s protocol. Telomerase immortalization of RAD50-
deﬁcient ﬁbroblasts was accomplished by infection of primary
skin ﬁbroblasts with a retroviral vector encoding hTERT (pBABE-
puro-hTERT; Addgene, Cambridge, MA) as previously described.32
RAD50 cDNA was also subcloned into the pCLNXS retroviral
plasmid (Imgenex, SanDiego, CA)with the use of EcoRI and BamHI
sites. hTERT-immortalized RAD50(/) cells (YS8) were infected
with packaged viral particles and selected with G418. Expression
of RAD50 was tested with 13B3 Ab from GeneTex (San Antonio,
TX) via immunoblotting and IF. The results indicated that about
30% of the cells initially expressed the recombinant protein.
Cell Survival
Clonogenic cell survival after exposure to IR was carried out as
described previously.33 Control and F239 RAD50-deﬁcient cells
(ﬁbroblasts) were resuspended at 2 3 105/ml in cell-culture
medium. Cells were irradiated with 1, 2, 3, 4, or 5 Gy and plated
out for the determination of survival via counting of surviving
colonies. The A-T ﬁbroblast line AT4BI was included as a radiosen-
sitive control. Survival data were derived from three separate
experiments.
Cytogenetic Analysis
Both blood lymphocytes and LCLs were examined for sponta-
neous and radiation-induced chromosomal instability. Exponen-
tially growing cells were irradiated in the G2 phase of the cell cycle
with doses of 0.5 or 1 Gy, respectively. Colcemid (0.06 mg/ml) wasThe Amadded to the cultures 2 hr after irradiation, and the cells were har-
vested 2 hr later. Metaphases were GTG banded via pancreatin and
Giemsa staining. Chromosome aberrations were scored according
to ISCN nomenclature. Chromosome painting was performed via
standard hybridization procedures with whole-chromosome paint
(WCP) probes for chromosomes 1, 2, 4, 7, and 14 (Vector Labora-
tories, Burlingame, CA).
DNA-Replication Labeling and DNA-Fiber Spreads
Cells were labeled consecutively with 15 mM Chlorodeoxyuridine
(CldrU) for 20 min, including a mock or 5 Gy treatment, then
a further 20 min with 15 mM Iododeoxyuridine (IdrU). DNA ﬁbers
were prepared as described elsewhere.34 In brief, 2 ml of cells
(1 3 106 cells/mL) were mixed with 6 ml lysis solution (0.5%
SDS, 200 mM Tris-HCl pH 7.4 and 50 mM EDTA), and after
10 min, slides were tilted to 20 to spread the DNA ﬁbers. Slides
were air dried both before and after ﬁxation in methanol:acetic
acid (3:1). DNA ﬁbers were denatured in 2.5 M HCl for 60 min
and immunolabelled with rat monoclonal anti-bromodeoxyuri-
dine (BrdrU) (BU1/75, Abcam) and anti-rat Alexa 488-conjugated
secondary antibody (Molecular Probes) for labeling of CldrU, fol-
lowed by mouse monoclonal anti-BrdrU (Becton Dickinson) and
donkey anti-mouse Alexa 594-conjugated secondary antibody
(Molecular Probes) for labeling of IdrU as previously described.35
DNA tracks were scored (300–500) for each cell line for mock
and 5 Gy treatments. The percentage of newDNA tracks was deter-
mined (new initiations/continuing tracks 3 100), and the
percentage of inhibition of DNA synthesis was computed as
[(irradiated new initiations/continuing) / (unirradiated new initia-
tions/continuing)] 3 100.
Results
Patient Phenotype
Previously, a four-year-old girl of nonconsanguineous
German descent had been reported as having an NBS-like
condition.36 Her diagnosis was based on typical congenital
and laboratory ﬁndings, including microcephaly, growth
retardation, spontaneous chromosomal instability includ-
ing characteristic translocations between chromosomes
7 and 14, cellular hypersensitivity to ionizing radiation,
and radioresistant DNA synthesis. By age 15, she presented
with mild to moderate retardation of psychomotor devel-
opment,mild spasticity, and verymodestly impaired senso-
motor coordination, which appeared as a subtle unsteadi-
ness in straight-line walking, resembling a slight and
nonprogressive ataxia. Physical examination also included
recognition of a ‘‘bird’’-like face and revealed height
(130 cm), weight (29 kg), and head circumference (43 cm)
well below the third percentile. Puberty and secondary
sexual characteristics appeared normal. Areas of hyper-
and hypopigmentation were noticed all over her body,
and she was suffering from a massive hyperopia. A photo-
graph and a summary of clinical ﬁndings are provided in
Figure S1 and Table S2. Of note, the girl had never experi-
enced severe or recurrent infections. Laboratory studies
performedwhen shewas18yearsold showednormal serum
levelsof immunoglobulin (Ig) classesG,A,M,D, aswell as oferican Journal of Human Genetics 84, 605–616, May 15, 2009 607
Figure 1. RAD50 Deficiency Associated with Two Germ-Line Mutations
(A–C) Immunoblot analysis of NBN, MRE11, and RAD50 in whole-cell extracts of either untreated () or 6 Gy irradiated (þ) patient-
derived lymphoblasts (HA239) (A and B) compared to normal control (WT, HA256) and A-T or NBS lymphoblasts (HA56, HA226) (B).
Immunoblot analysis of RAD50 in the patient-derived LCLs after strong overexposure of the blots, arrows pointing to weak bands consis-
tent with a normal-sized and a larger RAD50 variant (C).
(D) Analysis of the RAD50 sequence. An asterisk indicates two heteroallelic base substitutions, c.3277C/T (p.R1093X) and c.3939A/T
(p.X1313YextX*66) in the genomic RAD50 sequence (upper and middle panel). Only the allele carrying the mutation c.3939A/T was
observed in the RAD50 cDNA sequence (bottom panel).IgG subclasses, as had been observed previously, when
shewas a child.36 Lymphocyte counts, subset distributions,
and lymphocyte response to mitogen were within
normal limits, as was the level of serum alpha-fetoprotein.
There was no evidence of lymphoid malignancy such as
frequently occurs over time in individuals with an NBS
phenotype. At her current age of 23 years, the patient is
living in her own ﬂat in an assisted-living facility.
Mutations in the RAD50 Gene
The initial sequencing of the NBN gene did not reveal a
disease-causing mutation. Heterozygosity for a rare amino
acid substitution (p.R169H, c.506G/A in exon 5), which
could not explain a NBS phenotype, was noted. Immuno-608 The American Journal of Human Genetics 84, 605–616, May 15blot analysis of patient-derived lymphoblasts (HA239)
failed to reveal any radiation-induced phosphorylation of
NBN(Ser343). This observation prompted studies of NBN
interactors. Among them, RAD50 protein was undetect-
able, in contrast to that of classic NBS patients (Figures
1A and 1B). However, traces of residual RAD50 protein
were detected in LCLs after extended exposure of X-ray
ﬁlms, indicating a weak, normal-sized RAD50 protein
band and an isoform with an estimated 5-10 kDa increase
in its molecular weight (Figure 1C). Residual levels of
RAD50 protein were below 5% of WT. Although RAD50
protein was not detected at normal exposures of the auto-
radiographs (Figures 1A and 1B), the other components of
the MRN complex were easily detected (Figure 1B). Protein, 2009
levels of the other components of theMRN complex varied
from 20%–40% of WT for NBN and 30%–70% of WT for
MRE11, in different experiments (Figure 1B). Primary ﬁbro-
blasts from the same patient also had markedly reduced
levels of RAD50 (data not shown). Sequence analysis of
the entire coding region of RAD50 at cDNA (LCL) and
gDNA levels for both lymphocytes and ﬁbroblasts revealed
compound heterozygosity for mutations that are predicted
to be deleterious (Figure 1D). The maternally inherited
mutation (c.3277C/T;p.R1093X) is located in exon21and
creates a premature termination codon (Figure 1D, upper
panel). The paternally inherited mutation (c.3939A/T),
located in exon 25, affects the RAD50 stop codon by
changing the ochre triplet at codon 1313 into a tyrosine
codon (Figure 1D, middle). Conceptual translation of
the paternal allele predicts a larger polypeptide than WT,
extended by 66 additional amino acids at the carboxy
terminal (p.X1313YextX*66). The prediction of a larger-
size polypeptide produced by the aberrant paternal allele
is consistent with the detection of a higher-molecular-size
proteinband (Figure1C).Thevery lowamountsof the larger
polypeptide could be consequence of protein instability
and/or of an unstable nonstop mRNA. Yet, this allele was
predominating; sequence analysis of cDNA showed quasi-
hemizygous expression of the paternal allele, c.3939A/T,
in lymphoblast mRNA, implying nonsense-mediated mRNA
decay for the maternal allele (Figure 1D, bottom panel).
Thus, most of the residual RAD50 protein appeared to be
derived from the paternal p.X1313YextX*66 allele. The exis-
tence of alternatively spliced RAD50 mRNA as speciﬁed in
the NCBI database may explain the observed traces of
normal-sized protein, though additional studies were
precluded by the extremely low amounts of protein in the
RAD50-deﬁcient cells. Screening of 350 chromosomes from
aGerman randompopulation sample failed to reveal either
of the twomutations noted in the patient, likely excluding
the possibility that these are polymorphic variants.37
Defect in Localization of RAD50 to Sites
of DNA Damage
Given that the human RAD50, MRE11, and NBN proteins
colocalize in large nuclear repair foci after irradiation,38
we investigatedwhether the patient’s ﬁbroblasts would still
be able to form irradiation-induced nuclear foci (IRIF). As
shown in Figure 2, NBN and RAD50 were diffusely distrib-
uted throughout the nucleus in normal control ﬁbroblasts
and relocated to distinct foci after irradiation (Figure 2A;
a–d, q–t). Predominantly nuclear staining for NBNwas also
apparent in the patient’s ﬁbroblasts, but therewere no IRIFs
(Figure 2A; e–h). Immunoﬂuorescence failed to detect
RAD50 in the patient’s ﬁbroblasts, irrespective of whether
the cells were irradiated or not (Figure 2A; u–x). Immunos-
taining of MRE11 showed diffuse and predominantly
nuclear distribution in control ﬁbroblasts. After IR, MRE11
was seen to accumulate within nuclear IRIF (Figure 2A; i–l).
In RAD50-deﬁcient cells, however, MRE11 staining was
predominantly cytoplasmic. This did not change after IR,The Amand there was no induction of MRE11-speciﬁc IRIFs (Fig-
ure 2A; m–p). Retroviral transduction of RAD50 cDNA into
hTERT-immortalized patient-derived ﬁbroblasts restored
both nuclear relocation of MRE11 and IRIF formation of
RAD50 and MRE11 in response to IR (Figure 2B). These
results indicated that intact RAD50 is essential for nuclear
localization of MRE11 and for DNA-damage-induced
recruitment ofNBNandMRE11 intonuclear foci. Innormal
lymphoblasts, MRE11 and RAD50 proteins could be coim-
munoprecipitated with antibodies against NBN (Figure S2)
andviceversa (datanot shown). Inpatient cells, the amount
of MRE11 coimmunoprecipitating with NBNwasmarkedly
reduced as compared to controls, indicating a stabilizing
function of RAD50 on the MRN complex (Figure S2).
ATM Activation and Signaling Is Defective
in RAD50-Deﬁcient Cells
IR-induced activation of ATM appears to be impaired in
NBN-deﬁcient cells.24 A commonly used biological marker
for ATM activation is its autophosphorylation at serine
residue 1981.25 In RAD50-deﬁcient ﬁbroblasts, DNA-
damage-induced ATM autophosphorylation was markedly
impaired after 5 Gy irradiation (Figure 3A). In addition,
there was little, if any, detectable phosphorylation of either
SMC1 on Ser957 or CHEK2 on Thr68, and radiation-
induced ATM-dependent phosphorylation of p53 on
Ser15was reduced by approximately 50% relative to control
cells (Figure 3A and data not shown). Similarly, in the
RAD50-deﬁcient LCL HA239, DNA-damage-induced ATM
autophosphorylation was impaired after 10 Gy irradiation
(Figure 3B). Additionally, there was very little detectable
phosphorylation of either SMC1 on Ser957 or NBN on
Ser343, and the radiation-induced ATM-dependent phos-
phorylation of p53 on Ser15 was reduced by ~50% relative
to control cells (Figure 3B and data not shown). Transient
transfectionofRAD50 cDNA intoRAD50-deﬁcient lympho-
blasts followed by irradiation restored phosphorylation of
p53(Ser15) and ATM(Ser1981), as well as of NBN(Ser343)
(Figure 3C). The effects of RAD50 deﬁciency were not
limited to the cellular ionizing radiation response, however;
p53 phosphorylation on Ser15 was also diminished after
hydroxyureatreatmentofRAD50-deﬁcientcells (Figure3D).
Phosphorylation of the ATR substrate CHEK1(Ser317) was
similarly reduced after exposure to hydroxyurea, to an
extent comparable with classic NBS cells, suggesting that,
by analogy with NBN39 and as reported for a RAD50-
depleted colon cancer cell line,40 RAD50 deﬁciency may
also impair ATR-dependent signaling pathways after repli-
cation fork stalling (Figure 3E).
RAD50-Deﬁcient Cells Exhibit Increased Cellular
and Chromosomal Radiosensitivity
A characteristic feature of cells with defective ATM activa-
tion is their hypersensitivity to IR. To address this in the
patient with RAD50 deﬁciency, we measured the clono-
genic survival of RAD50-deﬁcient ﬁbroblasts after irradia-
tion with different doses in between 1 and 5 Gy. As iserican Journal of Human Genetics 84, 605–616, May 15, 2009 609
Figure 2. Irradiation-Induced Interactions of NBN, MRE11, and RAD50
(A) Immunofluorescence of primary fibroblasts with mutant RAD50 (F239) compared with WT control fibroblasts assessed for their ability
to form ionizing radiation-induced foci (IRIF) for NBN, MRE11, and RAD50 in response to a radiation dose of 12 Gy; a–d, control
fibroblasts unirradiated and irradiated, stained with anti-NBN and DAPI nuclear stain, respectively; e–h, corresponding data for610 The American Journal of Human Genetics 84, 605–616, May 15, 2009
Figure 3. Role of RAD50 in ATM- and
ATR-Dependent Signaling
(A) Role of RAD50 in ATM-dependent
IR-induced signaling in fibroblasts. Impair-
ment of IR-induced ATM autophosphoryla-
tion and signaling to ATM substrates in
both A-T (AT5) and RAD50-deficient (F239)
fibroblasts compared with control fibro-
blasts (NFF).
(B) Role of RAD50 in ATM-dependent
IR-induced signaling in lymphoblastoid
cells. Impairment of the IR-induced
signaling to ATM substrates in both A-T-
(AT25ABR) and RAD50-deficient (HA239)
LCL compared with control cells (C2ABR).
(C) Restoration of radiation-induced phos-
phorylation of NBN (Ser343), as well as of
phosphorylation of p53 (Ser15) and ATM
autophosphorylation at Ser1981, after
transient transfection of RAD50 cDNA into
HA239 LCL.
(D) Comparative immunoblot analysis of
p53(Ser15) phosphorylation after treat-
ment of RAD50-deficient or control lympho-
blastoid cells with either hydroxyurea (HU,
1 mM, 1 hr) or ionizing radiation (6 Gy,
30 min), consistent with reduced p53 phos-
phorylation in RAD50- deficient cells.
(E) Immunoblot analysis of ATR-dependent
signaling to CHEK1 after hydroxyurea (HU)
treatment (1 mM, 1 hr) of RAD50-deficient
lymphoblastoid cells (HA239) in compar-
ison to NBS cells homozygous for the NBN
c.657del5 mutation (HA226) and to WT
control cells (HA256), consistent with
reduced CHEK1 phosphorylation in both
NBN- and RAD50-deficient cells.shown in Figure 4A, RAD50-deﬁcient ﬁbroblasts displayed
a signiﬁcantly lower proportion of surviving colonies than
did normal control ﬁbroblasts, although the extent of
radiosensitivity was somewhat lower than that in A-T
ﬁbroblasts (Figure 4A). We also investigated the level of
chromosomal radiosensitivity and were able to show that
RAD50-deﬁcient blood lymphocytes and lymphoblasts
showed an increased level of IR-induced chromosomal
damage similar that of to A-T and NBS cells (Table S3).
RAD50 deﬁciency was also associated with an increased
spontaneous chromosomal instability, as has been sug-
gested by the initial cytogenetic studies in this patient.36
Interestingly, RAD50-deﬁcient cells showed a particularlyThe Amhigh frequency of spontaneous chromatid exchanges
(Figure S3A, chte); 7.6 chte per 100 metaphases in lympho-
cytes and 2.7 chte per 100 metaphases in LCLs, detected
neither in A-T nor in NBS cells. All chte ﬁgures (multiradial
interchanges) involved nonhomologous chromosomes.
Further analyses by both G banding and WCP assays
revealed spontaneous translocations of chromosomes7 and
14 in 1.5%–4% of the patient lymphocytes, a frequency
lower than that observed in lymphocytes of NBS or A-T
patients (~10%–20%, refs. 5,41,42 and M.S., unpublished
data). Extended WCP assays including probes for chromo-
somes 1, 2, and 4 additionally disclosed a high rate of spon-
taneous translocations (23/1000 metaphases) (Figure S3B),RAD50-deficient cells, F239; i–l, control fibroblasts unirradiated and irradiated, stained with anti-MRE11 and DAPI, respectively; m–p,
corresponding analysis for F239 cells; q–t, control fibroblasts unirradiated and irradiated, stained with anti-RAD50 and DAPI, respec-
tively; u–x, corresponding analysis for F239 cells.
(B) Nuclear localization and foci formation of MRE11 and RAD50 is restored after transduction of RAD50 cDNA. RAD50-deficient fibroblasts
were immortalized with hTERT. Stable cell lines expressing WT RAD50 were established by transduction with a retroviral RAD50 vector
(YS8) and selection in G418. Cells were exposed to 12 Gy and IRIF for RAD50 and MRE11 determined in control fibroblasts (left panel),
uncomplemented F239 cells (middle panel), and RAD50-transduced F239 cells (right panel).erican Journal of Human Genetics 84, 605–616, May 15, 2009 611
Figure 4. Clonogenic Survival and Cell-Cycle Checkpoints
(A) Radiosensitivity in RAD50-deficient fibroblasts (F239) was measured by counting of colonies surviving radiation doses of 1–5 Gy.
Colony survival was expressed as a percentage of irradiated/unirradiated cells. Error bars represent SEM, and the data are derived from
three separate experiments. NFF, control; F239, RAD50-deficient cells; AT4B1, A-T cells.
(B) Univariate flow histograms of asynchronous RAD50-deficient LCL (HA239). Cells were irradiated at the indicated dosage levels and
harvested 48 hr later. G2-phase cell accumulation is indicated by an arrow. Quantitative analysis is shown in Table 1.in this case at a frequency comparable to that observed in
NBS or A-T cells43.In summary, RAD50-deﬁcient cells
showed a similar level of IR-induced chromosomal damage
compared with A-T or NBS cells. However, aberrations
spontaneously occurring in RAD50-deﬁcient cells appear
to include fewer translocations involving chromosomes
7 and14. In contrast, the predominance of chromatid inter-
changes (multiradials) that are due to successful but inaccu-
rate repair of chromatid-type lesions (DSBs) supposedly
reﬂects a role for RAD50 in homology-directed recombina-
tional DNA repair.
RAD50-Deﬁcient Cells Reveal G1/S and Intra-S
Checkpoint Defects and Accumulation
in G2 after Irradiation
NBS and A-T cells exhibit cell-cycle abnormalities that can
be assessed by ﬂow cytometric analysis.44,45 An early study
of thepresentpatient suggests that thisholds true, in similar
form, for RAD50-deﬁcient cells.36Whenwe increased levels
of irradiation from 0 to 8 Gy, S-phase fractions of HA239
LCL remained grossly unchanged, whereas they decreased
in a dose-dependent manner in normal control lympho-612 The American Journal of Human Genetics 84, 605–616, May 15,blasts (Figure 4B and Table 1). Likewise, with increasing
dosage levels of irradiation from 0 to 8 Gy, the G2-phase
fractions of HA239 lymphoblasts sharply increased in
a dose-dependent manner, whereas the G2-phase fractions
showed only slight increases within the same dosage range
in control lymphoblasts. Theseﬁndings suggest thatHA239
lymphoblasts are uninhibited by irradiation in entering
S phase (their S-phase fractions remain grossly unchanged)
and in their progress through S phase (their G2-phase
fractions strongly increase). These data provide direct and
Table 1. Cell-Cycle Distributions of Lymphoblast Cultures
48 Hr after Irradiation
IR Dosage (Gy)
HA239
G1 S G2 (%)
Wild-Type Control (CON)
G1 S G2 (%)
0.0 66.0 20.6 13.4 56.8 31.1 12.1
2.5 53.9 22.0 22.0 67.8 15.9 16.3
4.0 41.9 20.2 37.9 71.2 11.4 17.4
8.0 34.0 20.7 45.2 77.3 7.4 15.3
Proportions were calculated by curve fits of the histograms shown in
Figure 4B.2009
indirect evidence that the G1/S and intra-S checkpoints in
RAD50-deﬁcient lymphoblasts are compromised and that
the cells accumulate at the G2/M checkpoint at later
times after irradiation, similar to what has previously been
reported for A-T cells.44 Akin to lymphoblasts, RAD50-
deﬁcient lymphocytes and ﬁbroblasts showed comparable
G1 and S cell-cycle-checkpoint defects and accumulated
in G2 phase in a dose-dependent manner after IR.
Failure to inhibit DNA synthesis in response to IR treat-
ment to the same extent as that of controls is a hallmark of
A-T, NBS, and ATLD cells.46–48 This is referred to as radiore-
sistant DNA synthesis (RDS) and is used as a measure of the
intra-S-phase checkpoint. RDS is normally determined by
incorporation of radioactive nucleotides into DNA, which
is subject to considerable variability. Previous observations
suggest that both DNA-chain initiation and elongation are
resistant to IR-induced damage introduced into DNA of
A-Tcells.44 To address this, we have developed a DNA-repli-
cation assay to differentiate between chain elongation and
new initiations, with a view to increasing the sensitivity
of the assay (A.W.K., unpublished data). The assay involves
a short pulse with CldrU for labeling of existing chains,
followed by radiation exposure and a pulse with IudrU
for labeling of new initiations. The extent of DNA
synthesis is expressed as the ratio of new initiations to total
elongations. Under these conditions, WT ﬁbroblasts (NFF)
showed marked inhibition of DNA synthesis after radia-
tion, whereas RAD50-deﬁcient cells (F239) displayed RDS
(Table 2). Thus, consistent with data from a different
approach in an early report of this patient,36 radioresistant
DNA synthesis is an inherent feature of the patient0s cells
and might contribute to the genomic instability and radio-
sensitivity in this NBS-like disorder.
Discussion
This study identiﬁes and further characterizes RAD50muta-
tions as the underlying cause of a disease entity, RAD50
deﬁciency, that shows features of a Nijmegen Breakage
Syndrome-like disorder (NBSLD). To our knowledge, this
disease entity has not been previously published. The
cellular and clinical phenotype of RAD50 deﬁciency adds
an important piece of evidence to our knowledge of how
defects in DNA-damage signaling may relate to radiosensi-
tivity,neurodevelopmentaldisease, and immunodeﬁciency.
Because null mutations in RAD50—like those in MRE11A
and NBN—cause embryonic lethality in mice,49–51 most of
what we know about the developmental functions of the
MRN complex is presently based on hypomorphic inactiva-
tion ofNBN andMRE11A.4,52 The biallelic mutations in the
present case individual with RAD50 deﬁciency might also
result in a hypomorphic combination, given the evidence
for subtle amounts of residual RAD50 protein in her lym-
phoblastoid cells. This condition is associatedwith a clinical
phenotype resembling NBS rather than ATLD, suggesting
potential differences in the roles for MRE11 and RAD50 orThe AmNBN in neuronal development. The description of human
RAD50 deﬁciency in this study complements the series of
reports on defects in the MRN complex,4,38,52 important
for its bilateral interaction with ATM and for downstream
signaling in theDSB-repair pathways.A-TandNBS represent
the clinicallymost devastating anddivergent phenotypes of
the corresponding gene defects, whereas MRE11 deﬁciency
(ATLD) and RAD50 deﬁciency (NBSLD) can be regarded as
attenuated disorders of the former or latter, respectively.
They constitute variant forms without immunodeﬁciency
and malignancies (also with normal serum alpha-fetopro-
tein levels), such that affected individuals reach higher
mean ages than do individuals suffering from A-T or NBS.
This is also observed in the pattern of radiosensitivity in
whichRAD50-deﬁcient cells (F239) are intermediate in their
sensitivity between A-T and WT control cells and closely
resemble ATLD in this characteristic.4 Cells from patients
with classical NBS have a pattern of sensitivity more similar
to that of A-T.38
Like the NBN protein, MRE11 and RAD50 are regarded as
DSB sensors that are involved in the activation of ATM at
early time points after low doses of IR.13 RAD50 deﬁciency
was found to be associated with reduced ATM autophos-
phorylation and impaired radiation-induced phosphoryla-
tion of ATM target proteins, a ﬁnding consistent with the
proposed role of RAD50 in sensing IR-induced DNA
damage and in tethering DSBs.17,18 RAD50 deﬁciency
was also found to be associated with RDS and with
impaired function of G1- and S-phase cell-cycle check-
points; this may be a consequence of reduced ATM-medi-
ated phosphorylation of cell-cycle regulators such as p53
or SMC1.29–31 However, the role of RAD50 could also be
indirect, given that RAD50 deﬁciency impaired the nuclear
localization of MRE11 and its interaction with NBN. In
addition, mutational inactivation of RAD50 caused some
reduction in the expression levels of the remaining compo-
nents of the complex, similar to what was observed for
MRE11Amutations.4 But whereas RAD50 was not detected
at normal exposure conditions of autoradiographs, the
other components of the MRN complex were easily
detected at protein levels that are close to those expected
for ATLD or NBS heterozygotes. Because ATLD or NBS
Table 2. Radioresistant DNA Synthesis in RAD50-Deficient
(F239) Fibroblasts
New DNA Initiations (%)a
Cell Line Unirradiated Irradiated Inhibition (%)
NFF 7.6 (7.2, 8.0)b 1.5 (1.3, 1.6) 80
F239 10.1 (10.7, 9.4) 4.8 (5.5, 4.0) 52
a New DNA replication initiations were determined by sequential labeling
of cells with Cld Urd (existing chains) and Id Urd (new initiations), with
or without exposure to radiation between pulse labeling. Initiations are
standardized to total elongation in the fields of view.
b Average values for two experiments. NFF is the normal control fibroblast
and F239 is the RAD50 mutant. Between 80 and 155 fibers were scored for
the different samples.erican Journal of Human Genetics 84, 605–616, May 15, 2009 613
heterozygotes do not exhibit such marked cellular pheno-
types as described for the RAD50-deﬁcient cells, we
consider it unlikely that the downregulation of the NBN
and MRE11 proteins alone would be responsible for the
observed features. It may nevertheless be noteworthy
that the overall levels of MRE11 protein appeared more
stable than those of NBN in RAD50-deﬁcient cells, paralle-
ling the closer clinical relationship of RAD50 deﬁciency
with NBS than with ATLD (MRE11 deﬁciency). In both
NBS- and RAD50-deﬁcient cells, MRE11 is mainly detected
in the cytoplasm, suggesting that both proteins are
required for the nuclear localization of MRE11.38,53–55 It
remains possible that extranuclear functions of MRE11
can prevent to some extent the cerebellar ataxia that is
characteristic for A-T and ATLD but is not observed in
NBS and RAD50 deﬁciency. On the other hand, speciﬁc
roles of NBN and RAD50 in ATR-mediated signaling path-
ways could contribute to the microcephaly that has been
correlated with defects in ATR function56–58 but is not
observed in patients with A-T or ATLD. Interestingly,
RAD50 can form complexes with NBN and bind to DNA
in the absence of MRE11 in vitro.59 Perhaps the closer clin-
ical phenotype between NBS and RAD50 deﬁciency might
reﬂect a more critical role for NBN and RAD50 in down-
stream signaling to speciﬁc intermediates or pathways.31,60
Speciﬁc modiﬁcations to those downstream molecules,
such as phosphorylation, might also inﬂuence their activ-
ities at sites of DSBs or may impinge on functions unre-
lated to DNA-damage sensing.
In summary, we describe the ﬁrst patient with RAD50
deﬁciency, a very rare neurodegenerative disorder due to
biallelic RAD50 mutations. Our data corroborate the clin-
ical and molecular relationship among the three genes
encoding the components of the MRN complex, but they
also suggest potential differences, as apparent by micro-
cephaly associated with NBN and RAD50 deﬁciency in
contrast to MRE11A mutations. These ﬁndings and the
availability of patient-derived RAD50-deﬁcient cell lines
provide the basis for the further delineation of the biolog-
ical roles of RAD50 as an early participant in cellular DNA-
damage responses.
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